Antimycotic combination therapy in patients with acute myeloblastic leukemia.
Burkert
M
M
Department of Hematology, University of Mainz, FRG.
Fuhr
H G
HG
Mertelsmann
R
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000382:microbiology*; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy* / Q000453:epidemiology; D014031:Tobramycin / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
D000935:Antifungal Agents; D014640:Vancomycin; D000666:Amphotericin B; D005437:Flucytosine; D014031:Tobramycin